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A B S T R A C T
Background
Assisted reproductive technologies (ART) such as in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) bring together
gametes outside of the body to enhance the probability of fertilisation and pregnancy. Advanced sperm selection techniques are
increasingly being employed in ART, most commonly in cycles utilising ICSI. Advanced sperm selection techniques are thought to
improve the chance that structurally intact and mature sperm with high DNA integrity are selected for fertilisation. Advanced sperm
selection strategies include selection according to surface charge; sperm apoptosis; sperm birefringence; ability to bind to hyaluronic
acid; and sperm morphology under ultra-high magnification. These techniques theoretically improve ART outcomes.
Objectives
To evaluate the impact of advanced sperm selection techniques on ART outcomes.
Search methods
Systematic search of electronic databases (Cochrane Menstrual Disorders and Subfertility Group Specialised Register, the Cochrane
Central Register of ControlledTrials (CENTRAL), MEDLINE, EMBASE, PsycINFO, Cumulative Index toNursing and AlliedHealth
Literature (CINAHL), Latin American and Caribbean Health Science Information Database (LILACS)), trials registers (ClinicalTri-
als.gov, Current Controlled Trials, World Health Organization International Clinical Trials Registry Platform), conference abstracts
(Web of Knowledge) and grey literature (OpenGrey) for relevant randomised controlled trials. We handsearched the reference lists of
included studies and similar reviews. The search was conducted in May 2014.
Selection criteria
We included randomised controlled trials (RCTs) comparing an advanced sperm selection technique versus standard IVF or ICSI or
versus another advanced sperm selection technique. We excluded studies of sperm selection using ultra-high magnification (intracyto-
plasmicmorphologically selected sperm injection, or IMSI), as they are the subject of a separate Cochrane review. Quasi-randomised and
pseudo-randomised trials were excluded. Our primary outcome measure was live birth rate per woman randomly assigned. Secondary
outcome measures included clinical pregnancy per woman randomly assigned, miscarriage per clinical pregnancy and fetal abnormality
per clinical pregnancy.
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Data collection and analysis
Two review authors independently assessed eligibility of studies and risk of bias, and performed data extraction. Disagreements were
resolved by consultation with a third review author. Study investigators were consulted to resolve other queries that arose. Risk ratios
(RRs) were calculated with 95% confidence intervals (CIs). We planned to combine studies using a fixed-effect model, if sufficient data
were available. The quality of the evidence was evaluated using Grades of Recommendation, Assessment, Development and Evaluation
(GRADE) methods.
Main results
Two RCTs were included in the review. Both evaluated sperm selection by hyaluronanic acid binding for ICSI, but only one reported
live births. No studies were identified that were related to surface charge selection, sperm apoptosis or sperm birefringence.
One RCT compared hyaluronanic acid binding versus conventional ICSI. Live birth was not reported. Evidence was insufficient to
show whether there was a difference between groups in clinical pregnancy rates (RR 1.01, 95% CI 0.84 to 1.22, one RCT, 482 women).
This evidence was deemed to be of low quality, mainly as the result of poor reporting of methods and findings. Miscarriage data were
unclear, and fetal abnormality rates were not reported.
The other RCT compared two different hyaluronanic acid binding techniques, SpermSlow and physiological intracytoplasmic sperm
injection (PISCI). Evidence was insufficient to indicate whether there was a difference between groups in rates of live birth (RR 1.16,
95% CI 0.65 to 2.05, one RCT, 99 women), clinical pregnancy (RR 1.07, 95% CI 0.67 to 1.71, one RCT, 99 women) or miscarriage
(RR 0.76, 95% CI 0.24 to 2.44, one RCT, 41 women). The evidence for these comparisons was deemed to be of low quality, as it was
limited by imprecision and poor reporting of study methods. Fetal abnormality rates were not reported.
Authors’ conclusions
Evidence was insufficient to allow review authors to determine whether sperm selected by hyaluronanic acid binding improve live birth
or pregnancy outcomes in ART, and no clear data on adverse effects were available. Evidence was also insufficient to show whether there
is a difference in efficacy between the hyaluronic acid binding methods SpermSlow and PICSI. No randomised evidence evaluating
sperm selection by sperm apoptosis, sperm birefringence or surface charge was found.
Further studies of suitable quality are required to evaluatewhether any of these advanced sperm selection techniques can be recommended
for use in clinical practice.
P L A I N L A N G U A G E S U M M A R Y
Advanced sperm selection techniques for assisted reproduction
Review question
Cochrane review authors reviewed the evidence on advanced sperm selection techniques for assisted reproduction. We sought studies of
all advanced sperm techniques apart from ultra-high magnification, which is the subject of a separate Cochrane review. Our outcomes
of interest included live birth, clinical pregnancy, miscarriage and fetal abnormalities.
Background
In vitro fertilisation (IVF) with or without intracytoplasmic sperm injection (ICSI) is a commonly used treatment for subfertile couples.
It is thought that selection of high-quality sperm may improve live birth rates for these couples. Advanced sperm selection techniques
use complex methods to select healthy, mature and structurally sound sperm for fertilisation. Despite use of these techniques in many
centres worldwide, their effectiveness is unclear.
Study characteristics
Two randomised controlled trials (with a total of 581 women) were included in the review. Both studies evaluated sperm selection
by hyaluronanic acid binding for ICSI, but only one reported live birth. One study compared hyaluronanic acid binding versus
conventional ICSI and reported clinical pregnancy. The other study compared two different hyaluronanic acid binding techniques,
SpermSlow and physiological intracytoplasmic sperm injection (PICSI), and reported live birth, clinical pregnancy and miscarriage
rates. No studies were found on other techniques. Evidence is current to May 2014.
Key results
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Current evidence was insufficient to permit evaluation of the effectiveness of advanced sperm selection strategies in assisted reproductive
technologist (ART). No evidence showed a difference between the groups in terms of any of the reported outcomes. Further studies of
suitable quality are required before any of these advanced sperm selection techniques can be recommended for use in clinical practice.
Evidence quality
The evidence gathered was of low quality. The main limitations were imprecision, discrepancies in the data and poor reporting of study
methods. Data on important clinical outcomes such as live births and adverse effects were scant.
3Advanced sperm selection techniques for assisted reproduction (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Conventional sperm selection (ICSI) versus hyaluronan selected sperm (HA-ICSI) for assisted reproduction
Population: women with infertility requiring assisted reproductive technology
Settings: ART
Intervention: hyaluronan sperm selection (HA-ICSI)
Comparison: conventional sperm selection (ICSI)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Conventional sperm se-
lection (ICSI)
Hyaluronan sperm se-
lection (HA-ICSI)
Clinical pregnancy per
woman randomly as-
signed
47 per 100 48 per 100
(39-57)
RR 0.99
(0.82-1.20)
482
(1 study)
⊕⊕©©
lowa,b
*The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison
group and the relative effect of the intervention (and its 95% CI).
ART: assisted reproductive technologies; CI: confidence interval; OR: odds ratio.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
aSerious risk of bias: discrepancy in reporting of pregnancy losses.
bSerious imprecision: confidence intervals compatible with substantial benefit or harm from the intervention, or with no effect.
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B A C K G R O U N D
Description of the condition
In vitro fertilisation (IVF) is a form of assisted reproductive tech-
nology (ART) that is used for treating infertility-a condition af-
fecting an estimated 15% of the population. IVF usually involves
controlled ovarian hyperstimulation, surgical oocyte retrieval, in
vitro fertilisation and embryo transfer. Intracytoplasmic sperm in-
jection (ICSI) involves injecting a single sperm into the cytoplasm
of each oocyte to achieve fertilisation. ICSI is commonly used as
treatment for male factor infertility when semen parameters are
poor, when sperm have been surgically retrieved or when repeated
fertilisation with standard IVF has failed (Palermo 1992).
Successful embryo development and subsequent pregnancy out-
come are likely to be impacted by the quality of the sperm that
fertilise an oocyte (Sakkas 2000). Ideally only sperm with a high
chance of successful fertilisation and subsequent embryo growth
would be used for ART. These sperm would be viable and mature,
would have high DNA integrity and would be structurally sound.
Spermpreparation and selection in IVF are limited to semenwash-
ing, density gradient centrifugation anduse of swim-up techniques
(Boomsma 2007). In ICSI, routine sperm selection is based on
motility and gross morphology (sperm are examined under a mi-
croscope at 200× to 400× magnification) after one or more of
the above methods of semen preparation has been applied. Ad-
vanced sperm selection techniques based on alternative character-
istics might enable further selection of themost appropriate sperm
for use in ART.
Description of the intervention
Advanced sperm selection techniques have developed as ameans of
improving ART outcomes in certain clinical scenarios. Techniques
can be categorised as follows.
Surface charge selection
Electrophorectic sperm selection and sperm zeta potential are sur-
face charge selection protocols utilised in both IVF and ICSI. The
zeta potential of the sperm is the electrical potential between the
sperm membrane and its surroundings. The zeta potential de-
creases with capacitation, and normally differentiated sperm are
charged electronegatively. Semen is placed into an electrophoretic
device and a current applied. Normally differentiated negatively
charged sperm are rapidly separated and collected from an adja-
cent chamber (Ainsworth 2005).
Sperm apoptosis
Selection of non-apoptotic sperm for use in ART is based on the
presence of phosphatidylserine on the external surface of the sperm
membrane in the early stages of apoptosis. Magnetic activated cell
sorting (MACS) and glass wool separation columns utilise the
magnetic properties of phosphatidylserine to separate apoptotic
sperm from non-apoptotic sperm (Grunewald 2001).
Hyaluronic acid binding
Hyaluronic acid (HA) is the main component of the extracellular
matrix of the cumulus oophorus. Hyaluronic acid binding sites
on the sperm plasma membrane indicate sperm maturity. Mature
sperm bind to and digest HA and thus have a better chance of
reaching the oocyte for fertilisation. In vitro, HA is utilised as a
’physiological selector’ of mature intact sperm.
Two systems for HA sperm selection are currently available. Phys-
iological intracytoplasmic sperm injection (PICSI; Origio, Måløv,
Denmark) is a plastic culture dish with spots of HA attached to its
base. Sperm are bound by the head to HA and are selected for mi-
croinjection (Huszar 2007). SpermSlow is a viscous medium con-
taining HA. Appropriate sperm appear ’slowed’ and are selected.
Sperm birefringence
The mature sperm nucleus has high intrinsic birefringence due
to longitudinally orientated subacrosomal protein filaments.With
the use of polarised light microscopy, sperm birefringence can be
evaluated and a mature sperm selected (Gianaroli 2008).
Sperm morphology (intracytoplasmic
morphologically selected sperm injection, IMSI)
Subtle defects in sperm morphology (acrosome, nucleus, mito-
chondria, tail, postacrosoma lamina and neck) can be observed
using ultra-highmagnification (6000×) microscopy (motile sperm
organelle morphology examination, MSOME) (Bartoov 2002).
Intracytoplasmicmorphologically selected sperm injection (IMSI)
is a modification of ICSI that uses this technique (Bartoov 2003).
This review does not evaluate IMSI, as it is the subject of another
Cochrane review (Teixeira 2013).
How the intervention might work
Each sperm selection modality utilises different characteristics of
sperm structure, physiology or function to promote selection of
the most normal sperm. Selection of the most appropriate sperm
for fertilisation in vitro may help improve fertilisation and the
quality of embryos created. Advanced sperm selection protocols
aim to improve ART outcomes and may limit possible deleterious
effects on offspring of using sperm with defective DNA (Aitken
2007).
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Why it is important to do this review
Advanced sperm selection techniques are hypothesised to improve
ART outcome through the selection of sperm with a variety of
’beneficial characteristics.’ Although individual small studies have
suggested that these techniques have clinical benefit, there remains
no comprehensive review of randomised controlled trials (RCTs)
in this area. The current review includes only RCTs, so the results
can better guide clinical practice and further research efforts.
O B J E C T I V E S
To evaluate the impact of advanced sperm selection techniques on
ART outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Published and unpublished RCTs investigating the impact of ad-
vanced sperm selection techniques in ART were eligible for inclu-
sion. Non-randomised studies were excluded because of high risk
of bias. Cross-over studies are inappropriate in this context and
were excluded.
Types of participants
Women or couples undergoing ART.
Types of interventions
Trials comparing an advanced sperm selection technique with ei-
ther another advanced sperm selection technique or an advanced
sperm selection technique with standard sperm preparation tech-
niques (e.g. semenwashing, density gradient centrifugation, swim-
up techniques).
Advanced sperm selection techniques include the following.
• Surface charge selection.
• Sperm apoptosis.
• Hyaluronic acid binding.
• Sperm birefringence.
Sperm selection by sperm morphology using ultra-high magni-
fication (IMSI) was excluded, as this is the subject of another
Cochrane review (Teixeira 2013).
Types of outcome measures
Primary outcomes
Effectiveness
• Live birth per woman randomly assigned.
(Live birth is defined as the delivery of a live fetus beyond 20
completed weeks’ gestation.)
Secondary outcomes
Effectiveness
• Clinical pregnancy per woman randomly assigned.
(Clinical pregnancy is defined as identification of a gestational sac
on ultrasound at ≥ seven weeks’ gestation.)
Adverse events
• Miscarriage, fetal abnormalities per clinical pregnancy.
(Miscarriage is defined as pregnancy loss at < 20 completed weeks’
gestation, or when the fetus weighs < 500 grams. Miscarriage must
be confirmed by ultrasound and pregnancy test or histology and
includes partial loss of multiple pregnancies.)
Fertilisation rates, implantation rates and outcomes related to em-
bryo development and quality are of importance to this review
and are described under Characteristics of included studies. These
outcomes were not included in the meta-analysis because stan-
dardised grading systems for morphology are lacking, and denom-
inators for fertilisation and implantation rates differ.
Search methods for identification of studies
We searched for all published and unpublished RCTs using the
search terms ’IVF,’ ’ICSI,’ ’ART,’ ’sperm selection,’ ’sperm prepa-
ration,’ ’sperm parameter,’ ’Hyaluronic acid,’ ’PICSI,’ ’apoptosis,’
’DNA,’ ’membrane maturity,’ ’magnetic cell sorting,’ ’morphol-
ogy,’ ’intracytoplasmic morphologically selected sperm injection,’
’polarization microscopy,’ ’polscope’ and ’sperm birefringence.’
The search included no language restriction and was designed and
conducted by SM and BK, in consultation with the Menstrual
Disorders and Subfertility Group (MDSG) Trials Search Co-or-
dinator. The search was conducted in May 2014.
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Electronic searches
We searched the following electronic databases, trial registers and
websites.
• Menstrual Disorders and Subfertility Group (MDSG)
Specialised Register
• Cochrane Central Register of Controlled Trials
(CENTRAL)
• MEDLINE
• EMBASE
• PsycINFO
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL)
Other electronic sources of trials included the following.
• Trial registers for ongoing and registered trials: http://
www.controlled-trials.com, http://clinicaltrials.gov/ct2/home,
http://www.who.int/trialsearch/Default.aspx.
• Citation indexes: http://scientific.thomson.com/products/
sci/.
• Conference abstracts in the Web of Knowledge: http://
wokinfo.com/
• Latin American and Caribbean Health Science Information
Database (LILACS), for trials from the Portuguese and Spanish-
speaking world: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/
online/?IsisScript=iah/iah.xis&base=LILACS&lang=i&form=F.
• PubMed: http://www.ncbi.nlm.nih.gov/pubmed/.
• Open System for Information on Grey Literature in Europe
(OpenSIGLE) database (http://opensigle.inist.fr/) and Google
Scholar for grey literature.
Searching other resources
We searched the reference lists of articles retrieved by the search.
Data collection and analysis
Selection of studies
After an initial screen of titles and abstracts retrieved by the search,
we retrieved the full texts of all potentially eligible studies. Two
review authors (SM and BK) independently examined these full-
text articles for compliance with the inclusion criteria and selected
studies eligible for inclusion in the review. We corresponded with
study investigators as required to clarify study eligibility. Disagree-
ments as to study eligibility were resolved by discussion or by dis-
cussion with a third review author (AY). We documented the se-
lection process by using a PreferredReporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) flow chart.
Data extraction and management
Two review authors independently extracted data from eligible
studies. Disagreements were resolved by discussion or by consul-
tation with a third review author. Data extracted included study
characteristics and outcome data and details of methods, partici-
pants, setting, context, interventions (sperm selection protocols),
outcomes, results and publications.We attempted to contact study
investigators via email to obtain additional information.No replies
were received from any of the study authors.
Assessment of risk of bias in included studies
Two review authors (SM and BK) independently assessed the in-
cluded studies for risk of bias using the Risk of bias assessment tool
of The Cochrane Collaboration (Higgins 2011). This instrument
assessed random sequence generation and allocation concealment
(selection bias); blinding of participants and personnel; blinding
of outcome assessors; incomplete outcome data; selective report-
ing; and other bias. Disagreements were resolved by discussion or
by consultation with a third review author (AY). We have fully
described all judgements and have presented our conclusions in
the Risk of bias table, which we planned to incorporate into the
interpretation of review findings by means of sensitivity analyses.
We took care to search for within-trial selective reporting, such as
trials failing to report obvious outcomes, or trials reporting out-
comes in insufficient detail to allow inclusion. We sought pub-
lished protocols and compared outcomes between the protocol
and the final published study.
Measures of treatment effect
The data extracted were dichotomous (e.g. live birth rate, miscar-
riage rate). Using RevMan software (RevMan 2011), we entered
the numbers of events in control and intervention groups of each
study to calculateMantel-Haenszel risk ratios (RRs).We presented
95% confidence intervals (CIs) for all outcomes.
Unit of analysis issues
The primary analysis was performed per woman randomly as-
signed. Per-pregnancy data were included for some miscarriage
outcomes. We briefly summarised data that did not allow valid
analysis (e.g. ’per cycle’ data), but did not meta-analyse these data.
If studies reported only ’per-cycle’ data, we attempted to contact
the study authors to obtain ’per-woman randomised’ data.
We counted multiple live births (e.g. twins, triplets) as a single live
birth event.
Dealing with missing data
We analysed the data on an intention-to-treat basis as far as pos-
sible and made attempts to obtain missing data from the original
trialists. When the data could not be obtained, we assumed that
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the outcome measure (e.g. live birth, clinical pregnancy) did not
occur. For other outcomes, we analysed available data.We planned
to subject any imputation undertaken to sensitivity analysis (see
below).
Assessment of heterogeneity
We considered whether the clinical and methodological charac-
teristics of the included studies were sufficiently similar for meta-
analysis to provide a clinically meaningful summary. We planned
to assess statistical heterogeneity using the I2 statistic, with an I2
measurement greater than 50% indicating moderate heterogene-
ity (Higgins 2003; Higgins 2008). Substantial heterogeneity was
deemed to be greater than 60%. If substantial heterogeneity was
apparent, we planned to explore possible explanations using a sen-
sitivity analysis (see below) and to consider subgroup analyses. We
planned to take any statistical heterogeneity into account when
interpreting the results, especially if any variation in the direction
of effect was noted.
Assessment of reporting biases
Reporting bias was minimised by ensuring a comprehensive search
for eligible studies. If 10 or more studies were included in an
analysis, we planned to use a funnel plot to explore the possibility
of small-study effects (a tendency for estimates of the intervention
effect to be more beneficial in smaller studies).
Data synthesis
If the studies were sufficiently similar, we planned to combine data
using a fixed-effect model for the following comparisons.
• IVF versus advanced sperm selection technique, stratified
by individual sperm selection technique (refer to Description of
the intervention above for details).
• ICSI versus advanced sperm selection technique, stratified
by individual sperm selection technique.
• Advanced sperm selection technique versus another
advanced sperm selection technique.
We graphically displayed an increase in the risk of a particular
outcome, which may be beneficial (e.g. live birth) or detrimental
(e.g. adverse effects), in the meta-analysis to the right of the centre
line and a decrease in the risk of a particular outcome to the left
of the centre line.
We planned to calculate number needed to treat for an additional
beneficial outcome (NNTB), if significant findings were identi-
fied.
Subgroup analysis and investigation of heterogeneity
If sufficient data were available, we planned to conduct subgroup
analyses to identify separate evidence within the following sub-
groups.
• Sperm morphology: when the Kruger score is equal to or
less than 4%.
• Increased DNA fragmentation index (according to the
study cut-off ).
• Surgically retrieved sperm.
• Female participants over 38 years of age.
Sensitivity analysis
We planned to conduct sensitivity analyses for primary outcome
measures to determine whether the conclusions were robust to
arbitrary decisions made regarding eligibility and analysis. These
analyses would include consideration of whether the review con-
clusions would have differed if:
• eligibility were restricted to studies without high risk of bias;
• a random-effects model had been adopted; or
• alternative imputation strategies had been implemented.
Overall quality of the body of evidence: Summary of
findings table
We generated a Summary of findings table using GRADEpro soft-
ware. This table evaluated the overall quality of the body of evi-
dence for themain review outcomes, using GRADE criteria (study
limitations (i.e. risk of bias), consistency of effect, imprecision,
indirectness and publication bias). We justified, documented and
incorporated into the reporting of results for each outcome our
judgements about the quality of evidence (high, moderate or low).
R E S U L T S
Description of studies
Results of the search
The search strategy identified 1007 studies. Thirty studies were
potentially eligible and were retrieved in full text. Following pub-
lication of our protocol, a Cochrane review was published regard-
ing sperm selection by sperm morphology under ultra-high mag-
nification (Teixeira 2013). After discussion with the Cochrane
Menstrual Disorders and Subfertility Group, the scope of our re-
view was amended to exclude the use of ultra-high magnifica-
tion for sperm selection. Nine more studies were therefore ex-
cluded. Two studies met our inclusion criteria (Parmegiani 2012;
Worrilow 2013). Eight studies were excluded (see PRISMA flow
chart; Figure 1).We identified no suitable studies regarding sperm
selection by apoptosis, birefringence or surface charge. The re-
mainder of the meta-analysis therefore pertains to hyaluronic acid
binding only. See study tables Characteristics of included studies
and Characteristics of excluded studies.
8Advanced sperm selection techniques for assisted reproduction (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Study flow diagram.
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Included studies
Study design and setting
Two parallel-design RCTs were included in the review (Parmegiani
2012; Worrilow 2013). One was a single-centre study conducted
in Italy, and the other was a multi-centre study, performed at 10
IVF programs in the USA. Two further conference abstracts were
identified that contained data from the above two trials; these have
been listed as secondary references.
Participants
• The first study (Parmegiani 2012) included 49 women in
the PICSI group and 50 in the SpermSlow group. No study arm
received standard ICSI only. Couples were included if the
woman was ≤ 41 years of age, ICSI treatment was to be utilised,
total sperm number was ≥ 1 million and sperm motility was ≥
5%. Couples using sperm collected surgically or with severe
oligoasthenoteratozoospermia were excluded.
• The second study (Worrilow 2013) included 240 women in
the intervention group (PICSI) and 242 in the control group
(standard ICSI). Couples were included if they were receiving
ICSI as part of their ART treatment. Participants were excluded
if the woman was > 40 years old, or if testicular sperm was used.
Participants were divided into cohorts on the basis of the
proportion of sperm bound to hyaluronan in the unprocessed
sample. Participants were further excluded if HB binding was <
2%. Participants were divided into those with hyaluronan-bound
sperm between 2% and 65% or > 65%, and then were further
divided into study groups (intervention or control).
Interventions
• 1/2 studies compared PICSI versus SpermSlow.
• 1/2 studies compared PICSI versus standard ICSI.
Outcomes
• 1/2 studies reported live birth.
• 1/2 studies reported clinical pregnancy rate.
• 1/2 studies reported miscarriage rate.
Excluded studies
Eight studies were excluded from the review for the following
reasons.
• 4/8 were not RCTs (Berkovitz 2006; Fleming 2007; Gnosh
2007; Parmegiani 2010b).
• 2/8 were pseudo-randomised (Gianaroli 2008; Gianaroli
2010).
• 1/8 did not analyse a relevant intervention (Blanchard
2010).
• 1/8 analysed participants per treatment randomly assigned
(Parmegiani 2010a), and despite attempts to contact the study
investigators, we were unable to obtain “per-woman” data.
Nine studies pertaining to IMSIwere excluded, as this intervention
is the subject of a separate Cochrane review (Teixeira 2013).
Risk of bias in included studies
See Characteristics of included studies; Figure 2; and Figure 3 for
detailed information.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence allocation
One study was at low risk of bias related to sequence generation:
it used computer-generated randomisation (Worrilow 2013). The
other study was at unclear risk of bias, as the method of random
sequence generation was not reported (Parmegiani 2012).
Allocation concealment
One study was at low risk of bias, as the investigator performing
randomisation had no involvement in the trial (Worrilow 2013).
Informationwas insufficient to permit judgement in the other trial
(Parmegiani 2012).
Blinding
One study was double-blinded (Worrilow 2013), and the other
was unblinded (Parmegiani 2012). Blinding however is unlikely
to affect any of the outcome measures. Both studies were judged
to be at low risk of bias for this domain.
Incomplete outcome data
In one study the risk of attrition bias was unclear, as it could not
be accurately determined which study group participants with in-
complete data belonged to (Worrilow 2013). Data were incom-
plete in 4/482; therefore the risk in this domain was not consid-
ered high. The other study was deemed to be at low risk of bias in
this domain (Parmegiani 2012).
Selective reporting
One study was considered to be at high risk of selective reporting
bias, as data regarding all outcome measures were not available
(Worrilow 2013). The remaining study was deemed to be at low
risk of selective reporting bias (Parmegiani 2012). No evidence
was found to suggest that specific outcomes were reported on the
basis of statistical significance.
Other potential sources of bias
One study was potentially biased, as it was stopped prematurely
because of financial constraints and a slower than expected time
to recruit (Worrilow 2013).
Effects of interventions
See: Summary of findings for the main comparison
Conventional sperm selection (ICSI) versus hyaluronan sperm
selection (HA-ICSI) for assisted reproduction; Summary of
findings 2 HA culture dish (PICSI) compared with viscous
medium containing HA (SpermSlow) for infertility requiring
intracytoplasmic sperm injection
See Summary of findings for the main comparison. Conventional
sperm selection (ICSI) versus hyaluronan selected sperm (HA-
ICSI); Summary of findings 2. HA culture dish (PICSI) versus
viscous medium containing HA (SpermSlow).
HA culture dish (PICSI) versus ICSI
Primary outcome
Live birth (effectiveness)
Live birth was not reported in the included study.
Secondary outcomes
Clinical pregnancy (effectiveness)
Evidence was insufficient to show whether there is a difference
between the interventions (RR 0.99, 95% CI 0.82 to 1.20, one
RCT, 482 women, low-quality evidence; Analysis 1.1; Figure 4).
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Figure 4. Forest plot of comparison. Hyaluronan sperm selection (HA-ICSI) versus ICSI, outcome: 1.1
Clinical pregnancy per woman randomly assigned.
Miscarriage (adverse event)
Pregnancy loss ratewas included in the reported study; however the
data were not suitable for meta-analysis. From the data provided,
we were unable to accurately determine to which treatment group
a miscarriage pertained.
Fetal abnormality (adverse event)
The included study did not report fetal abnormality.
HA culture dish (PICSI) versus viscous medium
containing HA (SpermSlow)
Primary outcome
Live birth (effectiveness)
Evidence was insufficient to show whether there is a difference
between the interventions in live birth rates (RR 1.16, 95% CI
0.65 to 2.05, one RCT, 99 women, low-quality evidence; Analysis
2.1; Figure 5).
Figure 5. Forest plot of comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA
(SpermSlow), outcome: 2.1 Live birth per woman randomly assigned.
Secondary outcomes
Clinical pregnancy (effectiveness)
Evidence was insufficient to show whether there is a difference
between the interventions in clinical pregnancy rates (RR 1.07,
95% CI 0.67 to 1.71, one RCT, 99 women, low-quality evidence;
Analysis 2.2; Figure 6).
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Figure 6. Forest plot of comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA
(SpermSlow), outcome: 2.2 Clinical pregnancy per woman randomly assigned.
Miscarriage (adverse event)
Evidence was insufficient to indicate whether there is a difference
between the interventions in miscarriage rates (RR 0.76, 95% CI
0.24 to 2.44, one RCT, 41 women, low-quality evidence; Analysis
2.3; Figure 7).
Figure 7. Forest plot of comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA
(SpermSlow), outcome: 2.3 Miscarriage per woman randomly assigned.
Fetal abnormality (adverse event)
The included study did not report fetal abnormality.
Secondary analyses
Data were insufficient for review authors to conduct any subgroup
or sensitivity analyses or to construct a funnel plot to assess report-
ing bias.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
HA culture dish (PICSI) compared with viscous medium containing HA (SpermSlow) for infertility requiring intracytoplasmic sperm injection
Population: women with infertility requiring intracytoplasmic sperm injection
Settings: ART
Intervention: HA culture dish (PICSI)
Comparison: viscous medium containing HA (SpermSlow)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Viscous medium con-
taining HA (SpermSlow)
HA culture dish (PICSI)
Live birth per woman
randomly assigned
30 per 100 35 per 100
(19-55)
RR 1.16
(0.65-2.05)
99
(1 study)
⊕⊕©©a,b
low
Clinical pregnancy per
woman randomly as-
signed
40 per 100 43 per 100
(25-62)
RR 1.07
(0.67-1.71)
99
(1 study)
⊕⊕©©a,b
low
Miscarriage per clinical
pregnancy
25 per 100 19 per 100
(5-51)
RR 0.76
(0.24-2.44)
41
(1 study)
⊕⊕©©a,b
low
*The basis for the assumed risk is the median control group risk across studies. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison
group and the relative effect of the intervention (and its 95% CI).
ART: assisted reproductive technologies; CI: confidence interval; HA: hyaluronic acid; OR: odds ratio.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
aSerious risk of bias: study methods not reported in adequate detail.15
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D I S C U S S I O N
Summary of main results
Overall, this review does not allow any conclusions to be drawn
regarding the use of advanced sperm selection techniques for as-
sisted reproduction.
Live birth rate was reported in only one included trial, and evi-
dence was insufficient to indicate whether there is a difference in
effectiveness between PICSI and SpermSlow.
Evidence was insufficient to show whether there is a difference in
clinical pregnancy rates between PICSI and standard ICSI or be-
tween PICSI and SpermSlow. Congenital abnormality outcomes
were not reported.
Data were insufficient to permit any conclusions with regard to
miscarriage.
No suitable studies were identified that would have allowed deter-
mination of the effect of sperm selected by surface charge, sperm
apoptosis or sperm birefringence. None of the included studies
reported a subgroup suitable for analysis. See Summary of findings
for the main comparison and Summary of findings 2 for further
details.
Overall completeness and applicability of
evidence
The objectives of this review were incompletely addressed by the
studies included. No suitably controlled data were available to ad-
dress the primary outcome measure (live birth per allocated cou-
ple) for any of the advanced sperm selection techniques described,
and data on other important clinical outcomes such as miscarriage
and fetal abnormalities were lacking.
Only one study (Worrilow 2013) provided data pertaining to clin-
ical pregnancy per allocated couple for hyaluronanic acid bind-
ing compared with standard ICSI. The other included study
(Parmegiani 2012) compared two different hyaluronanic acid
binding techniques-PICSI and SpermSlow-but did not include a
control population receiving standard ICSI. No study allowed a
suitable subgroup analysis.
Quality of the evidence
See Figure 2 and Figure 3.
The quality of the evidence for reported outcomes was low. The
main limitations were poor reporting of study methods, discrep-
ancies in the data and serious imprecision. The 95% confidence
intervals were compatible with substantial benefit or harm from
the intervention, or with no effect. Available RCT data were very
sparse, and the two included studies did not address the same clin-
ical comparison. We were unable to assess the risk of reporting
bias.
The included study for themain comparison (Worrilow 2013) had
several limitations. Overall the methodology was of a very poor
standard. Study findings were difficult to interpret, and absolute
values for outcome measures were not easily identifiable. The trial
was stopped early for financial reasons and slow recruitment; this
may have hindered the investigators’ ability to adequately complete
the stated objectives. It was unclear to which study group dropouts
belonged. Attempts weremade to contact the lead author to clarify
several findings; however no reply was forthcoming (see Summary
of findings for the main comparison).
Evidence on the comparison of two different hyaluronic acid bind-
ing methods for sperm selection (Parmegiani 2012) was similarly
limited by imprecision and by poor reporting of study methods
(see Summary of findings 2).
Potential biases in the review process
No potential biases were identified in the review process.
Agreements and disagreements with other
studies or reviews
Another systematic review (Said 2007) has addressed effects of
advanced sperm selection on sperm quality and ART outcomes.
Sperm selection techniques similar to those described in this review
were investigated. A total of 44 studies were identified, but few
were strictly randomised, andnearly all were deemedunsuitable for
inclusion in this review. However, the authors’ conclusions were in
concordance with our findings. Further clinical trials are required
before advanced sperm selection techniques can be recommended
in routine practice.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence is insufficient to show whether sperm selected by
hyaluronanic acid binding improves live birth or pregnancy out-
comes in ART, and no clear data on adverse effects are available.
Evidence is also insufficient to show whether there is a difference
in efficacy between hyaluronic acid binding methods-SpermSlow
and PICSI.
No randomised evidence describes evaluation of sperm selection
by sperm apoptosis, sperm birefringence or surface charge.
Implications for research
Suitable RCTs are needed to evaluate the effects of sperm selec-
tion based on hyaluronanic acid binding, surface charge selection,
sperm apoptosis and sperm birefringence on live birth, clinical
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pregnancy, miscarriage and congenital abnormality, and to inves-
tigate whether certain patient subgroups such as those with high
sperm DNA fragmentation might benefit from these advanced
sperm selection techniques. Trials should use intention-to-treat
analysis and should report outcomes per woman randomly as-
signed.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Parmegiani 2012
Methods Randomised controlled trial conducted in a single private assisted reproduction centre
(Italy) between September 2010 and March 2011
Participants Inclusion criteria: all infertile women aged ≤ 41 years; undergoing ICSI treatment;
total sperm number ≥ 1 million; sperm motility ≥ 5%
Exclusion criteria: testicular spermatozoa; severe oligoasthenoteratozoospermia; total
sperm number < 1 million; sperm motility < 5%
Randomly assigned: 99 participants
Interventions Couples were randomly assigned to 2 groups:
Intervention 1 (PICSI):A2-µLdroplet suspension of treated spermatozoa is placednear
each 5-µL culture (3 microdots in total) medium droplet and is subsequently connected
to the droplet using the tip of a Gilson pipette. The PICSI dish is incubated at 37°C
under oil (FertiCult Mineral Oil; FertiPro, Beernem, Belgium); within 5 minutes, the
bound spermatozoa attach by their head to the surface of the HA microdots and spin.
An ICSI injecting pipette (ICSI Micropipets; Humagen Fertility Diagnostics-Origio,
Jyllinge, Denmark) are used to pick HA-bound sperm and inject them 1 by 1 into
each oocyte. Spermatozoa spinning faster are preferred. The ICSI injecting pipette was
previously loaded with SpermSlow to facilitate sperm micromanipulation. 49 women
Intervention 2 (SpermSlow):On a plastic culture dish (IVF Petri dishes; Nunc, catalog
no. 150255), a 2-µL droplet suspension of treated spermatozoa is connected with a
pipette tip to a 5-µL droplet of fresh culture medium (FertiCult Flushing Medium).
Simultaneously, a 5-µL droplet of SpermSlow is connected with a pipette tip to a 5-µL
droplet of fresh culturemedium.The spermatozoa on this culture dish are then incubated
for 5 minutes at 37°C under oil (FertiCult Mineral Oil; FertiPro). Spermatozoa bound
to HA are slowed in the junction zone of the 2 droplets; these spermatozoa are selected
and collected with an injecting pipette (ICSI Micropipets) and then are injected into
oocytes. 50 women
Both PICSI and SpermSlow: PICSI and SpermSlow procedures are performed at 400×
magnification. The spermatozoa are selected according to their morphology (World
Health Organization guidelines 2010)
Outcomes Clinical pregnancy rate; miscarriage rate; live birth rate
Notes Study authors were emailed to clarify aspects of methodology, but no reply was received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of sequence generation not de-
scribed
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Parmegiani 2012 (Continued)
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judge-
ment: states that randomisation was “by
sealed envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk All participants were informed of their allo-
cated treatment. Given lack of blinding of
participants, it can be assumed that other
study personnel were unblinded. Lack of
blinding is unlikely to affect any of the out-
come measures
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk It is unclear whether blinding was per-
formed. Lack of blinding of outcome as-
sessment is unlikely to affect the outcomes
measured
Incomplete outcome data (attrition bias)
All outcomes
Low risk Omission of a single case is unlikely to
have a significant impact. Participant was
excluded because of high-risk ovarian hy-
perstimulation syndrome
Selective reporting (reporting bias) Low risk All prespecified outcomes have been re-
ported
Other bias Low risk None
Worrilow 2013
Methods Prospective, double-blind, randomised controlled trial conducted in 10 IVF programs
(USA). Period of enrolment not reported
Participants Inclusion criteria: IVF patients who received ICSI as part of their ART treatment
Exclusion criteria: use of testicular sperm; use of donor or cryopreserved gametes;
patients receiving PIGD; use of sperm sorting procedures; patients for whom only a
proportion of oocytes receive ICSI; maternal age > 40 years; < 4 metaphase 2 oocytes at
time of oocyte retrieval; initial hyaluronan binding score < 2%; sperm count < 10,000
motile sperm/mL
Randomly assigned: 482 participants
Interventions Participants were divided into 2 cohorts based on the proportion of HB sperm in their
unprocessed or initial semen (I-HB). The 2 cohorts were divided based on an I-HB ≤
65% or > 65%. Patients with an I-HB score ≤ 65% were randomly assigned to routine
ICSI (control) or sperm selection based on hyaluronan binding. Patients with an I-
HB score > 65% were randomly assigned to 3 groups: control, hyaluronan binding or
non-participation. The non-participating group was present to balance the numbers of
participants with high and low I-HB scores
The initial hyaluronan binding score of sperm was evaluated using the HBA Sperm
Hyaluronan Binding Assay, a dual-chambered slide containing an attached layer of
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Worrilow 2013 (Continued)
hyaluronan located beneath 2 individual coverslips (Biocoat, Inc., Horsham, PA, USA)
. In accordance with the manufacturer’s instructions, the HB score was determined by
calculating the number of motile HB spermdivided by the number of total motile sperm.
Following assessment of I-HB score, the sperm were subjected to centrifugation on a
discontinuous gradient and were washed with sperm processing media, according to the
specific protocol for the participating site
Intervention: The final sperm suspension was placed upon microdots of hyaluronan in
the PICSI Sperm Selection Device (Biocoat, Inc.) and was overlaid with oil. Following
a 5- to 10-minute incubation, HB sperm were selected for microinjection. 240 women
Control:The final sperm suspension was placed into standard ICSI dishes for selection.
242 women
Outcomes Clinical pregnancy rate; pregnancy loss rate
Notes Longer time than expected was taken to recruit participants; therefore the trial was
prematurely closed because of cost implications
Results for the study groups were combined to yield outcome measures regardless of
percentage of HB sperm
Study authors were contacted to clarify numerous areas of methodology and results. No
reply was received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Permuted block design with a computer
random number generator
Allocation concealment (selection bias) Low risk Investigator performing randomisation has
no clinical involvement in the trial
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Apart from embryologists, all participants
and personnel were blinded. Non-blinding
of embryologists is unlikely to affect the
outcome
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Information was insufficient to permit
judgement. Lack of blinding of outcome as-
sessment is unlikely to affect the outcomes
measured
Incomplete outcome data (attrition bias)
All outcomes
Low risk Results of 4 participants were not reported.
Overall, this was not a substantial depar-
ture from the intervention received. It is not
clear to which study group the incomplete
data belong
23Advanced sperm selection techniques for assisted reproduction (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Worrilow 2013 (Continued)
Selective reporting (reporting bias) High risk The outcome ’pregnancy loss rate’ was
incompletely reported. Absolute numbers
were not given and could not be deter-
mined from the information provided. The
absolute number of pregnancies given for
pregnancy loss was higher than that given
for clinical pregnancy. No explanation is
given
Other bias High risk Participant recruitment took longer than
expected; therefore the study was closed
prematurely because of higher than ex-
pected costs
Abbreviations:
ART: assisted reproductive technologies.
HB: hyaluronan binding.
HA: hyaluronic acid.
ICSI: intracytoplasmic sperm injection.
I-HB: initial hyaluronan binding.
IVF: in vitro fertilization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Antinori 2008 This study did not meet our inclusion criteria
Balaban 2011 This study did not meet our inclusion criteria
Berkovitz 2006 Not a randomised controlled trial (RCT) (couples were matched)
Blanchard 2010 The study did not analyse a relevant intervention
Figueira 2011 This study did not meet our inclusion criteria
Fleming 2007 Not a randomised controlled trial (RCT) (observational study)
Gianaroli 2008 The study was pseudo-randomised
Gianaroli 2010 The study was pseudo-randomised
Gnosh 2007 Not a randomised controlled trial (RCT) (observational study)
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(Continued)
Knez 2011 This study did not meet our inclusion criteria
Knez 2012 This study did not meet our inclusion criteria
Mahmoud 2011 This study did not meet our inclusion criteria
Parmegiani 2010a Results were ’per-treatment randomised’ rather than ’per-woman or couple randomised.’ Study authors were
contacted to adjust results, but no reply was received
Parmegiani 2010b This study did not meet our inclusion criteria
Setti 2011 This study did not meet our inclusion criteria
Setti 2012a This study did not meet our inclusion criteria
Setti 2012b This study did not meet our inclusion criteria
25Advanced sperm selection techniques for assisted reproduction (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Hyaluronan sperm selection (HA-ICSI) versus ICSI
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Clinical pregnancy per woman
randomly assigned
1 482 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.82, 1.20]
Comparison 2. HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Live birth per woman randomly
assigned
1 99 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.65, 2.05]
2 Clinical pregnancy per woman
randomly assigned
1 99 Risk Ratio (M-H, Fixed, 95% CI) 1.07 [0.67, 1.71]
3 Miscarriage per woman
randomly assigned
1 41 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.24, 2.44]
Analysis 1.1. Comparison 1 Hyaluronan sperm selection (HA-ICSI) versus ICSI, Outcome 1 Clinical
pregnancy per woman randomly assigned.
Review: Advanced sperm selection techniques for assisted reproduction
Comparison: 1 Hyaluronan sperm selection (HA-ICSI) versus ICSI
Outcome: 1 Clinical pregnancy per woman randomly assigned
Study or subgroup HA-ICSI ICSI Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Worrilow 2013 113/240 115/242 100.0 % 0.99 [ 0.82, 1.20 ]
Total (95% CI) 240 242 100.0 % 0.99 [ 0.82, 1.20 ]
Total events: 113 (HA-ICSI), 115 (ICSI)
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours ICSI Favours HA-ICSI
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Analysis 2.1. Comparison 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow),
Outcome 1 Live birth per woman randomly assigned.
Review: Advanced sperm selection techniques for assisted reproduction
Comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow)
Outcome: 1 Live birth per woman randomly assigned
Study or subgroup PICSI Sperm Slow Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Parmegiani 2012 17/49 15/50 100.0 % 1.16 [ 0.65, 2.05 ]
Total (95% CI) 49 50 100.0 % 1.16 [ 0.65, 2.05 ]
Total events: 17 (PICSI), 15 (Sperm Slow)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours SpermSlow Favours PICSI
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Analysis 2.2. Comparison 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow),
Outcome 2 Clinical pregnancy per woman randomly assigned.
Review: Advanced sperm selection techniques for assisted reproduction
Comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow)
Outcome: 2 Clinical pregnancy per woman randomly assigned
Study or subgroup PICSI Sperm Slow Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Parmegiani 2012 21/49 20/50 100.0 % 1.07 [ 0.67, 1.71 ]
Total (95% CI) 49 50 100.0 % 1.07 [ 0.67, 1.71 ]
Total events: 21 (PICSI), 20 (Sperm Slow)
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours SpermSlow Favours PICSI
Analysis 2.3. Comparison 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow),
Outcome 3 Miscarriage per woman randomly assigned.
Review: Advanced sperm selection techniques for assisted reproduction
Comparison: 2 HA culture dish (PICSI) versus viscous medium containing HA (SpermSlow)
Outcome: 3 Miscarriage per woman randomly assigned
Study or subgroup PICSI Sperm Slow Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Parmegiani 2012 4/21 5/20 100.0 % 0.76 [ 0.24, 2.44 ]
Total (95% CI) 21 20 100.0 % 0.76 [ 0.24, 2.44 ]
Total events: 4 (PICSI), 5 (Sperm Slow)
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours PICSI Favours Sperm Slow
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A P P E N D I C E S
Appendix 1. Menstrual Disorders and Subfertility Group keyword search
26.05.2014
Keywords CONTAINS “IVF” or “in vitro fertilization” or “in-vitro fertilisation” or “ICSI” or“intracytoplasmic sperm injection” or
“in-vitro fertilization” or “assisted reproduction” or “subfertility”or “infertility” or “male factor” or“male fertility” or “male infertility”
or “male subfertility” or “subfertility-male” or Title CONTAINS“IVF” or “in vitro fertilization” or “in-vitro fertilisation” or “ICSI”
or“intracytoplasmic sperm injection” or “in-vitro fertilization” or “assisted reproduction”or “subfertility”or “infertility” or “male factor”
or“male fertility” or “male infertility” or “male subfertility” or “subfertility-male”
AND
Keywords CONTAINS “sperm morphology”or “sperm motility”or “sperm preparation”or“sperm preparation techniques”or “sperm
select”or “sperm selection”or “sperm selection techniques”or“sperm separation”or “sperm sorting”or “birefringent sperm”or “Mag-
netic Activated Sorting Selection”or“magnetic sperm selection”or “hyaluronan-bound (HB) sperm”or “hyaluronan bound sperm”or
“hyaluronic acid sperm selection”or “hyaluronic acid intracytoplasmic sperm injection”or “IMSI”or “intracytoplasmic morphologically
selected sperm injection” or “apoptosis”or “semen preparation”or “membrane properties” or Title CONTAINS “sperm morphology”or
“spermmotility”or “sperm preparation”or“sperm preparation techniques”or “sperm select”or “sperm selection”or “sperm selection tech-
niques”or“sperm separation”or “sperm sorting”or “birefringent sperm”or “Magnetic Activated Sorting Selection”or“magnetic sperm
selection”or “hyaluronan-bound (HB) sperm”or “hyaluronan bound sperm”
Appendix 2. CENTRAL search strategy
26.05.2014
1 exp embryo transfer/ or exp fertilization in vitro/ or exp sperm injections, intracytoplasmic/ (1743)
2 embryo transfer$.tw. (1017)
3 vitro fertili?ation.tw. (1475)
4 ivf-et.tw. (288)
5 ivf.tw. (2170)
6 icsi.tw. (801)
7 intracytoplasmic sperm injection$.tw. (490)
8 (blastocyst adj2 transfer$).tw. (97)
9 assisted reproduct$.tw. (461)
10 ovulation induc$.tw. (517)
11 (ovari$ adj2 stimulat$).tw. (861)
12 superovulat$.tw. (148)
13 ovarian hyperstimulation.tw. (604)
14 COH.tw. (133)
15 infertil$.tw. (2085)
16 subfertil$.tw. (158)
17 (ovari$ adj2 induction).tw. (30)
18 exp Reproductive Techniques, Assisted/ (2440)
19 ART.tw. (1279)
20 or/1-19 (7011)
21 (sperm$ adj7 selection$).tw. (61)
22 (sperm$ adj7 separat$).tw. (48)
23 surface charge.tw. (8)
24 electrophore$.tw. (541)
25 (zeta adj2 potential).tw. (6)
26 magnetic cell sorting.tw. (1)
27 glass wool.tw. (4)
28 membrane matur$.tw. (1)
29 magnetic activated cell sort$.tw. (7)
30 ultramorpholog$.tw. (8)
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31 (hyaluronic acid adj2 binding).tw. (7)
32 (sperm$ adj5 birefringence).tw. (2)
33 (sperm$ adj3 morphology).tw. (147)
34 ultra high magnification.tw. (0)
35 motile sperm$ organelle.tw. (0)
36 MSOME.tw. (1)
37 IMSI.tw. (20)
38 Intracytoplasmic morphologically selected sperm injection$.tw. (17)
39 Raman spectroscopy.tw. (23)
40 confocal light absorption.tw. (0)
41 (scattering adj3 microscopy).tw. (2)
42 polarization microscopy.tw. (5)
43 polarisation microscopy.tw. (0)
44 polscope.tw. (3)
45 (sperm$ adj3 apopto$).tw. (10)
46 zeta method.tw. (0)
47 (nonapoptotic$ adj3 sperm$).tw. (1)
48 sperm$ preparation.tw. (58)
49 (sperm$ adj3 prepar$).tw. (97)
50 (semen adj2 prepar$).tw. (27)
51 (sperm$ adj5 chemotaxis).tw. (0)
52 hyaluronan bound.tw. (4)
53 (hyaluronic acid adj2 bound).tw. (1)
54 or/21-53 (964)
55 20 and 54 (230)
56 limit 55 to yr=“2013 -Current” (14)
Appendix 3. EMBASE search strategy
26.05.2014
1 (sperm$ adj7 selection$).tw. (1241)
2 (sperm$ adj7 separat$).tw. (1543)
3 surface charge.tw. (7586)
4 electrophore$.tw. (200594)
5 (zeta adj2 potential).tw. (8166)
6 magnetic cell sorting.tw. (676)
7 glass wool.tw. (441)
8 membrane matur$.tw. (64)
9 magnetic activated cell sort$.tw. (620)
10 ultramorpholog$.tw. (163)
11 (hyaluronic acid adj2 binding).tw. (395)
12 (sperm$ adj5 birefringence).tw. (27)
13 (sperm$ adj3 morphology).tw. (3995)
14 ultra high magnification.tw. (32)
15 motile sperm$ organelle.tw. (64)
16 MSOME.tw. (83)
17 IMSI.tw. (159)
18 Intracytoplasmic morphologically selected sperm injection$.tw. (111)
19 Raman spectroscopy.tw. (8853)
20 confocal light absorption.tw. (5)
21 (scattering adj3 microscopy).tw. (1180)
22 polarization microscopy.tw. (509)
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23 polarisation microscopy.tw. (42)
24 polscope.tw. (95)
25 (sperm$ adj3 apopto$).tw. (962)
26 zeta method.tw. (8)
27 (nonapoptotic$ adj3 sperm$).tw. (13)
28 sperm$ preparation.tw. (465)
29 (sperm$ adj3 prepar$).tw. (1489)
30 (semen adj2 prepar$).tw. (273)
31 (sperm$ adj5 chemotaxis).tw. (178)
32 hyaluronan bound.tw. (21)
33 (hyaluronic acid adj2 bound).tw. (40)
34 or/1-33 (235101)
35 exp embryo transfer/ or exp fertilization in vitro/ or exp intracytoplasmic sperm injection/ (52093)
36 embryo$ transfer$.tw. (12557)
37 in vitro fertili?ation.tw. (20392)
38 icsi.tw. (9487)
39 intracytoplasmic sperm injection$.tw. (6241)
40 (blastocyst adj2 transfer$).tw. (1069)
41 ivf.tw. (24351)
42 assisted reproduct$.tw. (12983)
43 ovulation induc$.tw. (4280)
44 (ovari$ adj2 stimulat$).tw. (6899)
45 superovulat$.tw. (2970)
46 ovarian hyperstimulation.tw. (5159)
47 COH.tw. (1457)
48 infertil$.tw. (53568)
49 subfertil$.tw. (4288)
50 (ovari$ adj2 induction).tw. (265)
51 exp infertility therapy/ (76551)
52 or/35-51 (127317)
53 Clinical Trial/ (831083)
54 Randomized Controlled Trial/ (342096)
55 exp randomization/ (62087)
56 Single Blind Procedure/ (18281)
57 Double Blind Procedure/ (113240)
58 Crossover Procedure/ (38945)
59 Placebo/ (239466)
60 Randomi?ed controlled trial$.tw. (98059)
61 Rct.tw. (13774)
62 random allocation.tw. (1301)
63 randomly allocated.tw. (20081)
64 allocated randomly.tw. (1916)
65 (allocated adj2 random).tw. (710)
66 Single blind$.tw. (14169)
67 Double blind$.tw. (139778)
68 ((treble or triple) adj blind$).tw. (362)
69 placebo$.tw. (196253)
70 prospective study/ (250502)
71 or/53-70 (1353706)
72 case study/ (25890)
73 case report.tw. (256873)
74 abstract report/ or letter/ (889492)
75 or/72-74 (1166690)
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76 71 not 75 (1316227)
77 34 and 52 and 76 (434)
78 (2013$ or 2014$).em. (2235119)
79 (2013$ or 2014$).dp. (262788)
80 78 or 79 (2235838)
81 77 and 80 (75)
Appendix 4. MEDLINE search strategy
26.05.2014
1 exp embryo transfer/ or exp fertilization in vitro/ or exp sperm injections, intracytoplasmic/ (32488)
2 embryo transfer$.tw. (8205)
3 vitro fertili?ation.tw. (16893)
4 ivf-et.tw. (1837)
5 ivf.tw. (16329)
6 icsi.tw. (5489)
7 intracytoplasmic sperm injection$.tw. (4956)
8 (blastocyst adj2 transfer$).tw. (549)
9 assisted reproduct$.tw. (9089)
10 ovulation induc$.tw. (3397)
11 (ovari$ adj2 stimulat$).tw. (4899)
12 superovulat$.tw. (2913)
13 ovarian hyperstimulation.tw. (3799)
14 COH.tw. (1141)
15 infertil$.tw. (42532)
16 subfertil$.tw. (3513)
17 (ovari$ adj2 induction).tw. (224)
18 exp Reproductive Techniques, Assisted/ (53012)
19 ART.tw. (49558)
20 or/1-19 (145434)
21 (sperm$ adj7 selection$).tw. (1002)
22 (sperm$ adj7 separat$).tw. (1487)
23 surface charge.tw. (7193)
24 electrophore$.tw. (204269)
25 (zeta adj2 potential).tw. (6747)
26 magnetic cell sorting.tw. (449)
27 glass wool.tw. (418)
28 membrane matur$.tw. (65)
29 magnetic activated cell sort$.tw. (398)
30 ultramorpholog$.tw. (172)
31 (hyaluronic acid adj2 binding).tw. (383)
32 (sperm$ adj5 birefringence).tw. (17)
33 (sperm$ adj3 morphology).tw. (3368)
34 ultra high magnification.tw. (13)
35 motile sperm$ organelle.tw. (31)
36 MSOME.tw. (38)
37 IMSI.tw. (57)
38 Intracytoplasmic morphologically selected sperm injection$.tw. (52)
39 Raman spectroscopy.tw. (10662)
40 confocal light absorption.tw. (5)
41 (scattering adj3 microscopy).tw. (1238)
42 polarization microscopy.tw. (514)
32Advanced sperm selection techniques for assisted reproduction (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
43 polarisation microscopy.tw. (38)
44 polscope.tw. (64)
45 (sperm$ adj3 apopto$).tw. (781)
46 zeta method.tw. (6)
47 (nonapoptotic$ adj3 sperm$).tw. (10)
48 sperm$ preparation.tw. (360)
49 (sperm$ adj3 prepar$).tw. (1339)
50 (semen adj2 prepar$).tw. (203)
51 (sperm$ adj5 chemotaxis).tw. (166)
52 hyaluronan bound.tw. (18)
53 (hyaluronic acid adj2 bound).tw. (42)
54 or/21-53 (237463)
55 randomized controlled trial.pt. (374162)
56 controlled clinical trial.pt. (88396)
57 randomized.ab. (294053)
58 randomised.ab. (58894)
59 placebo.tw. (158322)
60 clinical trials as topic.sh. (169995)
61 randomly.ab. (212907)
62 trial.ti. (126568)
63 (crossover or cross-over or cross over).tw. (60716)
64 or/55-63 (944515)
65 exp animals/ not humans.sh. (3940682)
66 64 not 65 (871027)
67 20 and 54 and 66 (246)
68 (2013$ or 2014$).ed. (1349970)
69 (2013$ or 2014$).dp. (1396112)
70 68 or 69 (1838941)
71 67 and 70 (39)
Appendix 5. PsycINFO search strategy
13.3.2013; no new results at 26.05.2014
1 (sperm$ adj7 selection$).tw. (86)
2 (sperm$ adj7 separat$).tw. (23)
3 surface charge.tw. (13)
4 electrophore$.tw. (842)
5 (zeta adj2 potential).tw. (5)
6 magnetic cell sorting.tw. (2)
7 glass wool.tw. (3)
8 membrane matur$.tw. (1)
9 magnetic activated cell sort$.tw. (2)
10 ultramorpholog$.tw. (2)
11 (hyaluronic acid adj2 binding).tw. (0)
12 (sperm$ adj5 birefringence).tw. (0)
13 (sperm$ adj3 morphology).tw. (35)
14 ultra high magnification.tw. (1)
15 motile sperm$ organelle.tw. (0)
16 MSOME.tw. (0)
17 IMSI.tw. (2)
18 Intracytoplasmic morphologically selected sperm injection$.tw. (0)
19 Raman spectroscopy.tw. (5)
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20 confocal light absorption.tw. (0)
21 (scattering adj3 microscopy).tw. (3)
22 polarization microscopy.tw. (1)
23 polarisation microscopy.tw. (0)
24 polscope.tw. (0)
25 (sperm$ adj3 apopto$).tw. (2)
26 zeta method.tw. (0)
27 (nonapoptotic$ adj3 sperm$).tw. (0)
28 sperm$ preparation.tw. (0)
29 (sperm$ adj3 prepar$).tw. (7)
30 (semen adj2 prepar$).tw. (1)
31 (sperm$ adj5 chemotaxis).tw. (6)
32 hyaluronan bound.tw. (1)
33 (hyaluronic acid adj2 bound).tw. (0)
34 or/1-33 (1032)
35 exp reproductive technology/ (1218)
36 in vitro fertili?ation.tw. (496)
37 ivf-et.tw. (17)
38 (ivf or et).tw. (89138)
39 icsi.tw. (39)
40 intracytoplasmic sperm injection$.tw. (33)
41 (blastocyst adj2 transfer$).tw. (2)
42 assisted reproduct$.tw. (469)
43 ovulation induc$.tw. (17)
44 (ovari$ adj2 stimulat$).tw. (47)
45 ovarian hyperstimulation.tw. (8)
46 COH.tw. (58)
47 superovulat$.tw. (5)
48 infertil$.tw. (2371)
49 subfertil$.tw. (56)
50 (ovari$ adj2 induction).tw. (4)
51 or/35-50 (92225)
52 random.tw. (37660)
53 control.tw. (293008)
54 double-blind.tw. (16852)
55 clinical trials/ (6705)
56 placebo/ (3440)
57 exp Treatment/ (544615)
58 or/52-57 (828902)
59 34 and 51 and 58 (4)
Appendix 6. CINAHL search strategy
26.05.2014
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# Query Results
S56 S41 AND S55 8
S55 S42 OR S43 or S44 or S45 OR S46 OR S47 OR S48OR S49
OR S50 OR S51 OR S52 OR S53 OR S54
891,112
S54 TX allocat* random* 3,905
S53 (MH “Quantitative Studies”) 12,016
S52 (MH “Placebos”) 8,741
S51 TX placebo* 31,574
S50 TX random* allocat* 3,905
S49 (MH “Random Assignment”) 37,244
S48 TX randomi* control* trial* 72,875
S47 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl*
n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*)
or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1
mask*) )
715,853
S46 TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 105
S45 TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 0
S44 TX clinic* n1 trial* 163,316
S43 PT Clinical trial 75,963
S42 (MH “Clinical Trials+”) 174,859
S41 S8 AND S40 30
S40 S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR
S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR
S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR
S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR
S37 OR S38 OR S39
5,541
S39 TX (hyaluronic acid N2 bound) 1
S38 TX (hyaluronan bound) 1
S37 TX (sperm* N5 chemotaxis) 43
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(Continued)
S36 TX (sperm* N5 chemotaxis) 0
S35 TX (nonapoptotic* N3 sperm*) 0
S34 TX (nonapoptotic* N3 sperm*) 0
S33 TX zeta method 1
S32 TX (sperm* N3 apopto*) 17
S31 TX polscope 2
S30 TX (polarisation microscopy) 2
S29 TX (polarization microscopy) 9
S28 TX (scattering N3 microscopy) 10
S27 TX confocal light absorption 1
S26 TX Raman spectroscopy 77
S25 TX MSOME 2
S24 TX (motile sperm* organelle) 2
S23 TX (ultra high magnification) 1
S22 TX (sperm* N3 morphology) 90
S21 TX (sperm* N5 birefringence) 4
S20 TX (sperm* N5 birefringence) 0
S19 TX (hyaluronic acid N2 binding) 8
S18 TX ultramorpholog* 6
S17 TX (magnetic activated cell sort*) 12
S16 TX (membrane matur*) 16
S15 TX (glass wool) 8
S14 TX (magnetic cell sorting) 25
S13 TX(zeta N2 potential) 22
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(Continued)
S12 TX electrophore* 5,173
S11 TX (surface charge) 31
S10 TX(sperm* N3 separat*) 7
S9 TX(sperm* N3 selection*) 17
S8 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 3,443
S7 TX embryo* N3 transfer* 699
S6 TX ovar* N3 hyperstimulat* 301
S5 TX ovari* N3 stimulat* 223
S4 TX IVF or TX ICSI 1,134
S3 (MM “Fertilization in Vitro”) 1,348
S2 TX vitro fertilization 2,672
S1 TX vitro fertilisation 259
C O N T R I B U T I O N S O F A U T H O R S
Protocol
SM wrote the first draft of the protocol. BK wrote the revised draft of the protocol. EF contributed methodological and statistical
expertise to the protocol. AY commented on all drafts of the protocol, as well as methods and statistics. DG assisted with revision of
the protocol. YH provided technical expertise and will contribute in the analysis phase of the review.
Full review
SM wrote the draft. BK provided clinical input. EF and AY supplied methodological and statistical expertise. DG commented on the
revised draft. YH provided technical input.
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S O U R C E S O F S U P P O R T
Internal sources
• None, Not specified.
External sources
• None, Not specified.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Following completion of our protocol, a Cochrane review titled ’Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection
for assisted reproduction’ was published (Teixeira 2013). This publication considerably overlapped that of our protocol, and after
consultation with the Cochrane Menstrual Disorders and Subfertility Group in Auckland, the scope of our review was amended to
exclude the use of ultra-high magnification (IMSI) for sperm selection. The title of our review was amended accordingly.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗SpermRetrieval; Apoptosis [physiology]; Birefringence;Hyaluronic Acid [metabolism]; RandomizedControlledTrials as Topic; Sperm
Injections, Intracytoplasmic [∗methods]; Spermatozoa [∗physiology]
MeSH check words
Humans; Male
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